English

Eligibility Coronary Artery Disease NCT00671021

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients suffering from stable cad, on chronic asa therapy
Description

Coronary Artery Disease Stable | Aspirin chronic

Data type

boolean

Alias
UMLS CUI [1,1]
C1956346
UMLS CUI [1,2]
C0205360
UMLS CUI [2,1]
C0004057
UMLS CUI [2,2]
C0205191
patients willing to participate in the study and to sign the informed consent form
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
acute coronary syndrome or revascularization in the last 3 months prior to enrolment
Description

Acute Coronary Syndrome | Revascularization

Data type

boolean

Alias
UMLS CUI [1]
C0948089
UMLS CUI [2]
C0581603
concurrent ingestion of nonsteroidal anti-inflammatory drugs (nsaids, including cox-2 selective anti-inflammatory drugs), clopidogrel, ticlopidine, dipyridamole, warfarin or acenocoumarol
Description

Anti-Inflammatory Agents, Non-Steroidal | Cyclooxygenase 2 Inhibitors | clopidogrel | Ticlopidine | Dipyridamole | Warfarin | Acenocoumarol

Data type

boolean

Alias
UMLS CUI [1]
C0003211
UMLS CUI [2]
C1257954
UMLS CUI [3]
C0070166
UMLS CUI [4]
C0040207
UMLS CUI [5]
C0012582
UMLS CUI [6]
C0043031
UMLS CUI [7]
C0000956
frequent use (more than once a week) of non-prescription nsaids or drugs containing asa in the 10 days preceding enrolment
Description

Non-Prescription NSAIDs times/week | Pharmaceutical Preparations Containing Aspirin times/week

Data type

boolean

Alias
UMLS CUI [1,1]
C0013231
UMLS CUI [1,2]
C0003211
UMLS CUI [1,3]
C0456698
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C0332256
UMLS CUI [2,3]
C0004057
UMLS CUI [2,4]
C0456698
major surgical procedure within 1 month before enrolment
Description

Major surgery

Data type

boolean

Alias
UMLS CUI [1]
C0679637
hemorrhagic diathesis or known platelet dysfunction
Description

Bleeding tendency | Platelet dysfunction

Data type

boolean

Alias
UMLS CUI [1]
C1458140
UMLS CUI [2]
C0679429
platelet count outside the 100 to 450 x109/l range for technical reasons
Description

Platelet count abnormal | Relationship Technical Problem

Data type

boolean

Alias
UMLS CUI [1]
C0580317
UMLS CUI [2,1]
C0439849
UMLS CUI [2,2]
C1710348
hematocrit < 25% or haemoglobin < 100 g/l
Description

Hematocrit procedure | Hemoglobin measurement

Data type

boolean

Alias
UMLS CUI [1]
C0018935
UMLS CUI [2]
C0518015
patient undergoing dialysis for chronic renal failure
Description

Dialysis Chronic Kidney Failure

Data type

boolean

Alias
UMLS CUI [1,1]
C0011946
UMLS CUI [1,2]
C0022661
patient found to be asa resistant
Description

Patient Aspirin Resistant

Data type

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C0004057
UMLS CUI [1,3]
C0332325
Back to the top of the page

Similar models

Eligibility Coronary Artery Disease NCT00671021

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Coronary Artery Disease Stable | Aspirin chronic
Item
patients suffering from stable cad, on chronic asa therapy
boolean
C1956346 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C0004057 (UMLS CUI [2,1])
C0205191 (UMLS CUI [2,2])
Informed Consent
Item
patients willing to participate in the study and to sign the informed consent form
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Acute Coronary Syndrome | Revascularization
Item
acute coronary syndrome or revascularization in the last 3 months prior to enrolment
boolean
C0948089 (UMLS CUI [1])
C0581603 (UMLS CUI [2])
Anti-Inflammatory Agents, Non-Steroidal | Cyclooxygenase 2 Inhibitors | clopidogrel | Ticlopidine | Dipyridamole | Warfarin | Acenocoumarol
Item
concurrent ingestion of nonsteroidal anti-inflammatory drugs (nsaids, including cox-2 selective anti-inflammatory drugs), clopidogrel, ticlopidine, dipyridamole, warfarin or acenocoumarol
boolean
C0003211 (UMLS CUI [1])
C1257954 (UMLS CUI [2])
C0070166 (UMLS CUI [3])
C0040207 (UMLS CUI [4])
C0012582 (UMLS CUI [5])
C0043031 (UMLS CUI [6])
C0000956 (UMLS CUI [7])
Non-Prescription NSAIDs times/week | Pharmaceutical Preparations Containing Aspirin times/week
Item
frequent use (more than once a week) of non-prescription nsaids or drugs containing asa in the 10 days preceding enrolment
boolean
C0013231 (UMLS CUI [1,1])
C0003211 (UMLS CUI [1,2])
C0456698 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2,1])
C0332256 (UMLS CUI [2,2])
C0004057 (UMLS CUI [2,3])
C0456698 (UMLS CUI [2,4])
Major surgery
Item
major surgical procedure within 1 month before enrolment
boolean
C0679637 (UMLS CUI [1])
Bleeding tendency | Platelet dysfunction
Item
hemorrhagic diathesis or known platelet dysfunction
boolean
C1458140 (UMLS CUI [1])
C0679429 (UMLS CUI [2])
Platelet count abnormal | Relationship Technical Problem
Item
platelet count outside the 100 to 450 x109/l range for technical reasons
boolean
C0580317 (UMLS CUI [1])
C0439849 (UMLS CUI [2,1])
C1710348 (UMLS CUI [2,2])
Hematocrit procedure | Hemoglobin measurement
Item
hematocrit < 25% or haemoglobin < 100 g/l
boolean
C0018935 (UMLS CUI [1])
C0518015 (UMLS CUI [2])
Dialysis Chronic Kidney Failure
Item
patient undergoing dialysis for chronic renal failure
boolean
C0011946 (UMLS CUI [1,1])
C0022661 (UMLS CUI [1,2])
Patient Aspirin Resistant
Item
patient found to be asa resistant
boolean
C0030705 (UMLS CUI [1,1])
C0004057 (UMLS CUI [1,2])
C0332325 (UMLS CUI [1,3])
Back to the top of the page